Capgemini Capital Increase: Exercise of the over-allotment option

Texte intégral

(1)NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN. Press Contact: Christel Lerouge Tel. +33 1 47 54 50 76. Investor Relations: Manuel Chaves d’Oliveira Tel. +33 1 47 54 50 87. Capgemini Capital Increase: Exercise of the over-allotment option Paris, December 7, 2006 – Capgemini announced that, in connection with the capital increase launched on December 5, 2006, Lazard-NATIXIS and Morgan Stanley & Co. International Limited acting as Global Coordinators, Lead Managers and Joint Bookrunners, have exercised today in full and in anticipation of the deadline set by the transaction timetable, the 10 % over-allotment option granted to them by Capgemini, with respect to a total of 1,036,119 additional new shares. The 1,036,119 additional new shares are expected to be admitted for listing on the Eurolist market of Euronext Paris S.A. on December 13, 2006. Morgan Stanley & Co. International Limited had the option to intervene on the market in order to stabilize Capgemini’s shares up until the exercise of this over-allotment option, but no such stabilization transactions were carried out. Upon completion of the capital increase and taking into account the exercise of the over-allotment exercise of the over-allotment option, amount to approximately EUR 507.2 million, including issuance premium.. About Capgemini: Capgemini, one of the world’s foremost providers of Consulting, Technology and Outsourcing services, has a unique way of working with its clients, which it calls the Collaborative Business Experience. Through commitment to mutual success and achievement of tangible value, Capgemini helps business implement growth strategies, leverage technology, and thrive through the power of collaboration. Capgemini reported 2005 global revenues of EUR 6,954 million and employs approximately 65,000 people worldwide. More information is available at www.capgemini.com Access to the prospectus This capital increase was the subject of a prospectus approved by the Autorité des marches financiers (French financial markets authority) by visa no. 06-467 dated December 5, 2006. Copies of this prospectus are available free of charge from Lazard-NATIXIS and Morgan Stanley & Co.. WorldReginfo - 86fe84bb-7dda-4002-a623-a3113f89170c. option, 11,397,310 new shares have been issued. The gross proceeds of the issuance, after full.

(2) NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN International Limited, or at Capgemini's registered office located 11, rue de Tilsitt, 75017 Paris, as well as on the websites of Capgemini (www.capgemini.com) and of the Autorité des marchés financiers (www.amf-france.org). A summary of the prospectus will also be published in the form of a financial notice in a national financial newspaper. This prospectus consists of the annual report (document de référence) that Cap Gemini S.A. filed with the AMF on April 25, 2006, under number D.06-0323 and its update (actualisation) filed on December 5, 2006 under number D.06-0323-A01, and a note d’opération. Capgemini draws the attention of the public on the risk factor sections contained in the prospectus. A notice will be published in the Bulletin des annonces légales obligatoires (journal for mandatory legal announcements) of December 13, 2006 concerning the capital increase Warning This press release must not be published, released or distributed, directly or indirectly, in the United States, Canada, Japan or Australia. This press release and the information contained herein neither contain nor constitute an offer to sell or to subscribe to, or the solicitation of an order to purchase or to subscribe to, securities in any country other than France.. This document is not an invitation nor is it intended to be an inducement to engage in an investment activity for the purpose of Section 21 of the Financial Services and Markets Act 2000, as amended ("FSMA"). This document is in any event directed only at (i) persons outside the United Kingdom, or (ii) persons in the United Kingdom that are "qualified investors" within the meaning of Article 2(1)(e) of Directive 2003/71/EC including persons who, according to any relevant implementing measure in each relevant member state are also (a) authorized under the FSMA or otherwise having professional experience in matters relating to investments and qualifying as investment professionals under Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order") or (b) institutions or corporations qualifying as high net worth persons under article 49(2) (a) to (d) of the Financial Promotion Order, or (c) any other persons to whom this document can lawfully be addressed in application of Section 21 of FSMA (all such persons together being referred to as "Relevant Persons"). Any person in the United Kingdom who is not a Relevant Person should not act or rely on this document. The release, publication or distribution of this press release in certain jurisdictions may constitute a breach of applicable laws or regulations. Therefore, persons physically present in such jurisdictions and in which this press release is circulated, published or distributed must inform themselves about and comply with such laws and regulations. Lazard-NATIXIS and Morgan Stanley & Co. International Ltd. are acting exclusively for Capgemini and no one else in connection with the capital increase. They will not regard any other person (whether or not a recipient of this announcement) as their client and will not be responsible to anyone other than Capgemini for providing the protections afforded to their respective clients nor for giving advice in relation to the capital increase, the contents of this announcement or any transaction or arrangement referred to herein.. WorldReginfo - 86fe84bb-7dda-4002-a623-a3113f89170c. This document does not constitute an offer of securities for sale nor the solicitation of an offer to purchase securities in the United States. Securities may not be offered or sold in the United States unless they are registered under the U.S. Securities Act of 1933, as amended, (“US Securities Act”), or are exempt from such registration. The shares of Cap Gemini referred to in this press release have not been and will not be registered under the U.S. Securities Act and Cap Gemini does not intend to make a private placement or a public offer of such securities in the United States..

(3)